Last updated: 2 July 2024 at 9:36pm EST

Group, Llc Green Jeremy Red... Net Worth




The estimated Net Worth of Group, Llc Green Jeremy Red... is at least $30.4 Million dollars as of 26 December 2023. Group Red owns over 44,630 units of AlloVir stock worth over $10,017,095 and over the last 9 years Group sold ALVR stock worth over $20,408,456.

Group Red ALVR stock SEC Form 4 insiders trading

Group has made over 28 trades of the AlloVir stock since 2015, according to the Form 4 filled with the SEC. Most recently Group bought 44,630 units of ALVR stock worth $166,024 on 26 December 2023.

The largest trade Group's ever made was buying 3,703,704 units of AlloVir stock on 25 September 2018 worth over $50,000,004. On average, Group trades about 218,464 units every 32 days since 2015. As of 26 December 2023 Group still owns at least 13,180,388 units of AlloVir stock.

You can see the complete history of Group Red stock trades at the bottom of the page.



Insiders trading at AlloVir

Over the last 4 years, insiders at AlloVir have traded over $46,310,999 worth of AlloVir stock and bought 5,850,170 units worth $60,516,413 . The most active insiders traders include Sciences, Inc. Gilead, Group, Llc Green Jeremy Red..., and Ansbert Gadicke. On average, AlloVir executives and independent directors trade stock every 9 days with the average trade being worth of $40,307. The most recent stock trade was executed by Diana Brainard on 20 August 2024, trading 5,390 units of ALVR stock currently worth $3,989.



What does AlloVir do?

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is Viralym-M, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Its preclinical and clinical development product candidates include ALVR106 for respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108 to treat human herpesvirus-8, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's diseases. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.



What does AlloVir's logo look like?

AlloVir, Inc. logo

Complete history of Group Red stock trades at Amicus Therapeutics Inc, Fate Therapeutics Inc, Syros Pharmaceuticals, Zymeworks BC Inc, Xeris Biopharma Inc, Allakos Inc, Replimune Inc, Vapotherm Inc, Gritstone Bio Inc, Hookipa Pharma Inc, Akero Therapeutics Inc, Atreca Inc, Cabaletta Bio Inc, Pliant Therapeutics, Repare Therapeutics, Neoleukin Therapeutics, TCR2 Therapeutics, Aprea Therapeutics, Beam Therapeutics, IGM Biosciences, Stoke Therapeutics, Nurix Therapeutics, Kymera Therapeutics, Shattuck Labs, and AlloVir

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
26 Dec 2023 Group, Llc Green Jeremy Red...
Buy 44,630 $3.72 $166,024
26 Dec 2023
13,180,388
20 Apr 2023 Group, Llc Green Jeremy Red...
Buy 276,639 $6.17 $1,706,863
20 Apr 2023
13,135,758
13 Apr 2023 Group, Llc Green Jeremy Red...
Sale 302,339 $5.84 $1,765,660
13 Apr 2023
12,833,419
8 Jan 2021 Group, Llc Green Jeremy Red...
Buy 327,485 $85.50 $27,999,968
8 Jan 2021
12,957,222
11 Jun 2020 Group, Llc Green Jeremy Red...
Buy 1,412,928 $28.31 $39,999,992
11 Jun 2020
12,629,737
16 Sep 2019 Group, Llc Green Jeremy Red...
Buy 857,143 $17.50 $15,000,003
16 Sep 2019
11,216,809
25 Sep 2018 Group, Llc Green Jeremy Red...
Buy 3,703,704 $13.50 $50,000,004
25 Sep 2018
10,359,666
29 Jun 2023 Group, Llc Green Jeremy Red...
Buy 80,423 $9.42 $757,585
29 Jun 2023
2,974,186
4 Sep 2020 Group, Llc Green Jeremy Red...
Buy 144,806 $50.52 $7,315,599
4 Sep 2020
3,425,811
1 Sep 2020 Group, Llc Green Jeremy Red...
Buy 136,649 $47.21 $6,451,199
1 Sep 2020
3,281,005
28 Dec 2020 Group, Llc Green Jeremy Red...
Sale 500,000 $5.58 $2,790,000
28 Dec 2020
1,768,718
7 Oct 2019 Group, Llc Green Jeremy Red...
Buy 400,000 $15.00 $6,000,000
7 Oct 2019
2,268,718
14 Oct 2020 Group, Llc Green Jeremy Red...
Buy 3,441,176 $17.34 $59,669,992
14 Oct 2020
5,619,914
27 Mar 2020 Group, Llc Green Jeremy Red...
Buy 194,300 $10.35 $2,011,005
27 Mar 2020
4,051,045
19 Feb 2019 Group, Llc Green Jeremy Red...
Buy 588,000 $10.00 $5,880,000
19 Feb 2019
3,000,642
25 Jun 2018 Group, Llc Green Jeremy Red...
Buy 666,668 $15.00 $10,000,020
25 Jun 2018
2,412,642
6 Jul 2016 Group, Llc Green Jeremy Red...
Buy 432,746 $12.50 $5,409,325
6 Jul 2016
49,793
3 Jun 2016 Group, Llc Green Jeremy Red...
Buy 66,300 $7.20 $477,360
3 Jun 2016
12,956,446


AlloVir executives and stock owners

AlloVir executives and other stock owners filed with the SEC include: